Innovation and progress in cancer research require dedication to the career development of the next generation of cancer researchers. Accordingly, the University of Kentucky?s Markey Cancer Center (MCC), with a robust annual institutional investment of $450,000 and the dedication of its members, established a comprehensive Oncology Career Enhancement Program. Over the past funding cycle, this program has provided enriching experiences for nearly 570 K-12 and undergraduate students; extensive research training for 50 high school students, 223 undergraduates and 544 graduate/postdoctoral researchers; and mentorship to 46 junior faculty. Notably, key education activities address the academic challenges of rural Appalachian Kentucky and underrepresented minorities through the support from 4 grants that include Continuing Umbrella of Research Experiences and Geographic Management of Health Disparities Program National Cancer Institute supplements. Academic and professional development of all trainees through intensive mentored research engagement and/or formal research training at the undergraduate, graduate and postdoctoral levels complement elementary and high school education strategies. Formal curricula in cancer biology have been established at the undergraduate, masters and pre-doctoral levels that provide the academic context for this training. Furthermore, 4 T32 training programs support cancer career development for trainees, including 2 funded by the National Cancer Institute, 1 of which is uniquely devoted to surgeon-scientists. Overall MCC training and career development extramural support has risen by 52% since 2012 to 26 grants totaling $2.3M (direct costs) in 2017. Early-career faculty benefit from team-based mentoring through formal mentoring committees, a Grant Writing Study Hall, the Clinical Trials Boot Camp and synergistic mentorship through various institutional efforts. This mentorship has resulted in 95 awarded grants (50 extramural, 45 intramural) and the development of 11 clinician scientists who went on to lead 31 clinical trials. A rich set of seminar, symposia, meetings and other career enhancement activities facilitate successful career development for all individuals engaged in cancer research and clinical practice. All current and proposed career enhancement activities leverage the robust research strengths within the MCC?s 4 Research Programs to provide immersive training across the pipeline and to ensure that faculty within these programs successfully develop as independent scientists. The MCC?s collective efforts also draw on strong institutional training resources to achieve 2 overarching goals of this program: to guide cohesive growth and coordinate transdisciplinary education and mentoring endeavors across the MCC; and to integrate with other efforts campus wide. Through CCSG support, this comprehensive program will continue to evolve innovative curricula and strategically linked initiatives that prepare trainees and early-career faculty for modern cancer career opportunities. Furthermore, these efforts will drive research innovation that will improve the lives of all Kentuckians.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA177558-07
Application #
9741640
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
7
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40526
Al-Darraji, Ahmed; Haydar, Dalia; Chelvarajan, Lakshman et al. (2018) Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease. PLoS One 13:e0200474
Jarrett, Stuart G; Carter, Katharine M; Bautista, Robert-Marlo et al. (2018) Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage. J Biol Chem 293:19025-19037
Zaytseva, Yekaterina Y; Rychahou, Piotr G; Le, Anh-Thu et al. (2018) Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer. Oncotarget 9:24787-24800
Choi, Yohan; Rosewell, Katherine L; Brännström, Mats et al. (2018) FOS, a Critical Downstream Mediator of PGR and EGF Signaling Necessary for Ovulatory Prostaglandins in the Human Ovary. J Clin Endocrinol Metab 103:4241-4252
Jiang, Kai; Liu, Yajuan; Zhang, Jie et al. (2018) An intracellular activation of Smoothened that is independent of Hedgehog stimulation in Drosophila. J Cell Sci 131:
Dhar, Sanjit K; Bakthavatchalu, Vasudevan; Dhar, Bithika et al. (2018) DNA polymerase gamma (Pol?) deficiency triggers a selective mTORC2 prosurvival autophagy response via mitochondria-mediated ROS signaling. Oncogene 37:6225-6242
Kim, Ji Tae; Napier, Dana L; Weiss, Heidi L et al. (2018) Neurotensin Receptor 3/Sortilin Contributes to Tumorigenesis of Neuroendocrine Tumors Through Augmentation of Cell Adhesion and Migration. Neoplasia 20:175-181
Engle, Jeff A; Traynor, Anne M; Campbell, Toby C et al. (2018) Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical center. J Oncol Pharm Pract 24:348-353
Pi, Fengmei; Binzel, Daniel W; Lee, Tae Jin et al. (2018) Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression. Nat Nanotechnol 13:82-89
Gedaly, Roberto; De Stefano, Felice; Turcios, Lilia et al. (2018) mTOR Inhibitor Everolimus in Regulatory T cell Expansion for Clinical Application in Transplantation. Transplantation :

Showing the most recent 10 out of 359 publications